Healthcare provider profile · identity verified

Kathrine Ann Walker

Nurse Practitioner · NORTH BRANFORD, CT · NPI 1497227854

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	406	125
Levothyroxine Sodium	Levothyroxine Sodium	394	113
Amlodipine Besylate	Amlodipine Besylate	342	84
Trazodone Hcl	Trazodone Hcl	341	79
Escitalopram Oxalate	Escitalopram Oxalate	220	55
Furosemide	Furosemide	213	54
Donepezil Hcl	Donepezil Hcl	195	25
Losartan Potassium	Losartan Potassium	193	61
Lisinopril	Lisinopril	190	61
Sertraline Hcl	Sertraline Hcl	182	37
Memantine Hcl	Memantine Hcl	173	21
Rosuvastatin Calcium	Rosuvastatin Calcium	170	47
Eliquis	Apixaban	168	27
Mirtazapine	Mirtazapine	158	48
Gabapentin	Gabapentin	145	40
Metoprolol Succinate	Metoprolol Succinate	144	45
Pantoprazole Sodium	Pantoprazole Sodium	142	46
Omeprazole	Omeprazole	139	32
Tamsulosin Hcl	Tamsulosin Hcl	129	33
Metformin Hcl	Metformin Hcl	128	40
Metoprolol Tartrate	Metoprolol Tartrate	115	24
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	95	61
Potassium Chloride	Potassium Chloride	95	22
Azelastine Hcl	Azelastine Hcl	91	44
Simvastatin	Simvastatin	87	27
Fluticasone Propionate	Fluticasone Propionate	86	43
Alprazolam	Alprazolam	85	29
Spironolactone	Spironolactone	83	14
Nystatin	Nystatin	80	44
Famotidine	Famotidine	76	18
Hydrochlorothiazide	Hydrochlorothiazide	75	26
Albuterol Sulfate Hfa	Albuterol Sulfate	74	47
Finasteride	Finasteride	74	12
Pravastatin Sodium	Pravastatin Sodium	74	20
Quetiapine Fumarate	Quetiapine Fumarate	70	18
Alendronate Sodium	Alendronate Sodium	67	suppressed
Carvedilol	Carvedilol	65	18
Atenolol	Atenolol	63	23
Doxycycline Hyclate	Doxycycline Hyclate	59	48
Mupirocin	Mupirocin	58	44
Metformin Hcl Er	Metformin Hcl	53	15
Risperidone	Risperidone	49	suppressed
Montelukast Sodium	Montelukast Sodium	48	15
Lorazepam	Lorazepam	45	16
Clopidogrel	Clopidogrel Bisulfate	43	11
Farxiga	Dapagliflozin Propanediol	43	12
Ibuprofen	Ibuprofen	43	21
Methenamine Hippurate	Methenamine Hippurate	43	12
Bupropion Xl	Bupropion Hcl	42	13
Triamcinolone Acetonide	Triamcinolone Acetonide	42	22
Fluoxetine Hcl	Fluoxetine Hcl	41	11
Valsartan	Valsartan	41	11
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	40	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	40	suppressed
Azithromycin	Azithromycin	39	34
Jardiance	Empagliflozin	39	15
Januvia	Sitagliptin Phosphate	38	11
Hydralazine Hcl	Hydralazine Hcl	37	suppressed
Prednisone	Prednisone	37	26
Duloxetine Hcl	Duloxetine Hcl	36	15
Allopurinol	Allopurinol	35	12
Entresto	Sacubitril/Valsartan	35	suppressed
Torsemide	Torsemide	35	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	34	16
Oxycodone Hcl	Oxycodone Hcl	33	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	32	suppressed
Clonazepam	Clonazepam	30	11
Erythromycin	Erythromycin Base	30	24
Levetiracetam	Levetiracetam	30	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	29	22
Meclizine Hcl	Meclizine Hcl	28	suppressed
Ondansetron Odt	Ondansetron	28	11
Tramadol Hcl	Tramadol Hcl	28	11
Ezetimibe	Ezetimibe	27	suppressed
Meloxicam	Meloxicam	27	14
Ondansetron Hcl	Ondansetron Hcl	27	11
Clotrimazole	Clotrimazole	26	15
Nifedipine Er	Nifedipine	26	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	26	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	26	11
Xarelto	Rivaroxaban	26	suppressed
Bumetanide	Bumetanide	25	suppressed
Cephalexin	Cephalexin	25	20
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Fluconazole	Fluconazole	24	18
Latanoprost	Latanoprost	24	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	24	suppressed
Glipizide Er	Glipizide	23	11
Paroxetine Hcl	Paroxetine Hcl	23	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	23	suppressed
Lacosamide	Lacosamide	22	suppressed
Timolol Maleate	Timolol Maleate	22	suppressed
Buspirone Hcl	Buspirone Hcl	21	suppressed
Terazosin Hcl	Terazosin Hcl	21	suppressed
Methotrexate	Methotrexate Sodium	20	suppressed
Ozempic	Semaglutide	19	suppressed
Valacyclovir	Valacyclovir Hcl	19	12
Lidocaine	Lidocaine	18	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	17
Methylprednisolone	Methylprednisolone	17	15
Metoclopramide Hcl	Metoclopramide Hcl	16	suppressed
Enalapril Maleate	Enalapril Maleate	15	suppressed
Glimepiride	Glimepiride	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Ketoconazole	Ketoconazole	15	suppressed
Lamotrigine	Lamotrigine	15	suppressed
Loperamide	Loperamide Hcl	15	suppressed
Amiodarone Hcl	Amiodarone Hcl	14	suppressed
Glipizide	Glipizide	14	suppressed
Nebivolol Hcl	Nebivolol Hcl	14	suppressed
Ofloxacin	Ofloxacin	14	12
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Synthroid	Levothyroxine Sodium	13	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Diazepam	Diazepam	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Pregabalin	Pregabalin	12	suppressed
Raloxifene Hcl	Raloxifene Hcl	12	suppressed
Edarbi	Azilsartan Medoxomil	11	suppressed
Febuxostat	Febuxostat	11	suppressed
Flecainide Acetate	Flecainide Acetate	11	suppressed
Gentamicin Sulfate	Gentamicin Sulfate	11	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	11	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	11	suppressed
Myrbetriq	Mirabegron	11	suppressed
Sucralfate	Sucralfate	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error